4yym - Revision history

OCA at 08:10, 27 September 2023

OCA — Wed, 27 Sep 2023 08:10:01 GMT

←Older revision		Revision as of 08:10, 27 September 2023
Line 4:		Line 4:
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[4yym]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4YYM OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4YYM FirstGlance]. <br>		<table><tr><td colspan='2'>[[4yym]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4YYM OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4YYM FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BTK:N~6~-BUTANOYL-L-LYSINE'>BTK</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene></td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 1.5Å</td></tr>
		+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BTK:N~6~-BUTANOYL-L-LYSINE'>BTK</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene></td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4yym FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4yym OCA], [https://pdbe.org/4yym PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4yym RCSB], [https://www.ebi.ac.uk/pdbsum/4yym PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4yym ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4yym FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4yym OCA], [https://pdbe.org/4yym PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4yym RCSB], [https://www.ebi.ac.uk/pdbsum/4yym PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4yym ProSAT]</span></td></tr>
	</table>		</table>

OCA at 07:31, 10 May 2023

OCA — Wed, 10 May 2023 07:31:18 GMT

←Older revision		Revision as of 07:31, 10 May 2023
Line 1:		Line 1:

	==Crystal structure of TAF1 BD2 Bromodomain bound to a butyryllysine peptide==		==Crystal structure of TAF1 BD2 Bromodomain bound to a butyryllysine peptide==
-	<StructureSection load='4yym' size='340' side='right' caption='[[4yym]], [[Resolution\|resolution]] 1.50Å' scene=''>	+	<StructureSection load='4yym' size='340' side='right'caption='[[4yym]], [[Resolution\|resolution]] 1.50Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4yym]] is a 3 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/~~Human Human~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4YYM OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4YYM FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4yym]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4YYM OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4YYM FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"~~><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene></td></tr>~~	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BTK:N~6~-BUTANOYL-L-LYSINE'>BTK</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene></td></tr>
-	~~<tr~~ id~~='NonStdRes'><td class~~="~~sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat~~"><scene name='pdbligand=BTK:N~6~-BUTANOYL-L-LYSINE'>BTK</scene><~~/td></tr>~~	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4yym FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4yym OCA], [https://pdbe.org/4yym PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4yym RCSB], [https://www.ebi.ac.uk/pdbsum/4yym PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4yym ProSAT]</span></td></tr>
-	~~<tr id~~='~~related'><td class~~=~~"sblockLbl"><b>[[Related_structure\|Related~~:~~]]</b></td><td class="sblockDat">[[4yy4\|4yy4]], [[4yy6\|4yy6]], [[4yyd\|4yyd]], [[4yyg\|4yyg]], [[4yyh\|4yyh]], [[4yyi\|4yyi]], [[4yyj\|4yyj]], [[4yyk\|4yyk]], [[4yyn\|4yyn]]</td></tr>~~	+
-	~~<tr id='gene~~'>~~<td class="sblockLbl"><b>[[Gene\|Gene:]]~~</b>~~</td><td class="sblockDat">TAF1, BA2R, CCG1, CCGS, TAF2A ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])~~</td></tr>	+
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4yym FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4yym OCA], [~~http~~://pdbe.org/4yym PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=4yym RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/4yym PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=4yym ProSAT]</span></td></tr>	+
	</table>		</table>
	== Disease ==		== Disease ==
-	[~~[http~~://www.uniprot.org/uniprot/TAF1_HUMAN TAF1_HUMAN]] Defects in TAF1 are the cause of dystonia type 3 (DYT3) [MIM:[~~http~~://omim.org/entry/314250 314250]]; also called X-linked dystonia-parkinsonism (XDP). DYT3 is a X-linked dystonia-parkinsonism disorder. Dystonia is defined by the presence of sustained involuntary muscle contractions, often leading to abnormal postures. DYT3 is characterized by severe progressive torsion dystonia followed by parkinsonism. Its prevalence is high in the Philippines. DYT3 has a well-defined pathology of extensive neuronal loss and mosaic gliosis in the striatum (caudate nucleus and putamen) which appears to resemble that in Huntington disease.<ref>PMID:12928496</ref> <ref>PMID:17273961</ref>	+	[https://www.uniprot.org/uniprot/TAF1_HUMAN TAF1_HUMAN] Defects in TAF1 are the cause of dystonia type 3 (DYT3) [MIM:[https://omim.org/entry/314250 314250]; also called X-linked dystonia-parkinsonism (XDP). DYT3 is a X-linked dystonia-parkinsonism disorder. Dystonia is defined by the presence of sustained involuntary muscle contractions, often leading to abnormal postures. DYT3 is characterized by severe progressive torsion dystonia followed by parkinsonism. Its prevalence is high in the Philippines. DYT3 has a well-defined pathology of extensive neuronal loss and mosaic gliosis in the striatum (caudate nucleus and putamen) which appears to resemble that in Huntington disease.<ref>PMID:12928496</ref> <ref>PMID:17273961</ref>
	== Function ==		== Function ==
-	[~~[http~~://www.uniprot.org/uniprot/TAF1_HUMAN TAF1_HUMAN]] Largest component and core scaffold of the TFIID basal transcription factor complex. Contains novel N- and C-terminal Ser/Thr kinase domains which can autophosphorylate or transphosphorylate other transcription factors. Phosphorylates TP53 on 'Thr-55' which leads to MDM2-mediated degradation of TP53. Phosphorylates GTF2A1 and GTF2F1 on Ser residues. Possesses DNA-binding activity. Essential for progression of the G1 phase of the cell cycle.<ref>PMID:2038334</ref> <ref>PMID:8450888</ref> <ref>PMID:8625415</ref> <ref>PMID:9660973</ref> <ref>PMID:9858607</ref> <ref>PMID:11278496</ref> <ref>PMID:15053879</ref>	+	[https://www.uniprot.org/uniprot/TAF1_HUMAN TAF1_HUMAN] Largest component and core scaffold of the TFIID basal transcription factor complex. Contains novel N- and C-terminal Ser/Thr kinase domains which can autophosphorylate or transphosphorylate other transcription factors. Phosphorylates TP53 on 'Thr-55' which leads to MDM2-mediated degradation of TP53. Phosphorylates GTF2A1 and GTF2F1 on Ser residues. Possesses DNA-binding activity. Essential for progression of the G1 phase of the cell cycle.<ref>PMID:2038334</ref> <ref>PMID:8450888</ref> <ref>PMID:8625415</ref> <ref>PMID:9660973</ref> <ref>PMID:9858607</ref> <ref>PMID:11278496</ref> <ref>PMID:15053879</ref>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 23:		Line 20:
	</div>		</div>
	<div class="pdbe-citations 4yym" style="background-color:#fffaf0;"></div>		<div class="pdbe-citations 4yym" style="background-color:#fffaf0;"></div>
		+
		+	==See Also==
		+	*[[Transcription initiation factors 3D structures\|Transcription initiation factors 3D structures]]
	== References ==		== References ==
	<references/>		<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: ~~Human~~]]	+	[[Category: Homo sapiens]]
-	[[Category: Bellon, S]]	+	[[Category: Large Structures]]
-	[[Category: Cochran~~, A G~~]]	+	[[Category: Bellon S]]
-	[[Category: Poy, F]]	+	[[Category: Cochran AG]]
-	[[Category: Tang, Y]]	+	[[Category: Poy F]]
-	~~[[Category: Bromodomain-butyryllysine complex]]~~	+	[[Category: Tang Y]]
-	~~[[Category: Protein binding~~]]	+

OCA at 17:06, 16 November 2017

OCA — Thu, 16 Nov 2017 17:06:19 GMT

←Older revision		Revision as of 17:06, 16 November 2017
Line 3:		Line 3:
	<StructureSection load='4yym' size='340' side='right' caption='[[4yym]], [[Resolution\|resolution]] 1.50Å' scene=''>		<StructureSection load='4yym' size='340' side='right' caption='[[4yym]], [[Resolution\|resolution]] 1.50Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4yym]] is a 3 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4YYM OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4YYM FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4yym]] is a 3 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4YYM OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4YYM FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene></td></tr>
	<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=BTK:N~6~-BUTANOYL-L-LYSINE'>BTK</scene></td></tr>		<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=BTK:N~6~-BUTANOYL-L-LYSINE'>BTK</scene></td></tr>
	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4yy4\|4yy4]], [[4yy6\|4yy6]], [[4yyd\|4yyd]], [[4yyg\|4yyg]], [[4yyh\|4yyh]], [[4yyi\|4yyi]], [[4yyj\|4yyj]], [[4yyk\|4yyk]], [[4yyn\|4yyn]]</td></tr>		<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4yy4\|4yy4]], [[4yy6\|4yy6]], [[4yyd\|4yyd]], [[4yyg\|4yyg]], [[4yyh\|4yyh]], [[4yyi\|4yyi]], [[4yyj\|4yyj]], [[4yyk\|4yyk]], [[4yyn\|4yyn]]</td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4yym FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4yym OCA], [http://pdbe.org/4yym PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4yym RCSB], [http://www.ebi.ac.uk/pdbsum/4yym PDBsum]</span></td></tr>	+	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">TAF1, BA2R, CCG1, CCGS, TAF2A ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4yym FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4yym OCA], [http://pdbe.org/4yym PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4yym RCSB], [http://www.ebi.ac.uk/pdbsum/4yym PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4yym ProSAT]</span></td></tr>
	</table>		</table>
	== Disease ==		== Disease ==
Line 26:		Line 27:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Human]]
	[[Category: Bellon, S]]		[[Category: Bellon, S]]
	[[Category: Cochran, A G]]		[[Category: Cochran, A G]]

OCA at 19:43, 9 March 2016

OCA — Wed, 09 Mar 2016 19:43:02 GMT

←Older revision		Revision as of 19:43, 9 March 2016
Line 1:		Line 1:
		+
	==Crystal structure of TAF1 BD2 Bromodomain bound to a butyryllysine peptide==		==Crystal structure of TAF1 BD2 Bromodomain bound to a butyryllysine peptide==
	<StructureSection load='4yym' size='340' side='right' caption='[[4yym]], [[Resolution\|resolution]] 1.50Å' scene=''>		<StructureSection load='4yym' size='340' side='right' caption='[[4yym]], [[Resolution\|resolution]] 1.50Å' scene=''>

OCA at 06:45, 30 September 2015

OCA — Wed, 30 Sep 2015 06:45:41 GMT

←Older revision		Revision as of 06:45, 30 September 2015
Line 1:		Line 1:
-	'''~~Unreleased~~ structure'''	+	==Crystal structure of TAF1 BD2 Bromodomain bound to a butyryllysine peptide==
		+	<StructureSection load='4yym' size='340' side='right' caption='[[4yym]], [[Resolution\|resolution]] 1.50Å' scene=''>
		+	== Structural highlights ==
		+	<table><tr><td colspan='2'>[[4yym]] is a 3 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4YYM OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4YYM FirstGlance]. <br>
		+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene></td></tr>
		+	<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=BTK:N~6~-BUTANOYL-L-LYSINE'>BTK</scene></td></tr>
		+	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4yy4\|4yy4]], [[4yy6\|4yy6]], [[4yyd\|4yyd]], [[4yyg\|4yyg]], [[4yyh\|4yyh]], [[4yyi\|4yyi]], [[4yyj\|4yyj]], [[4yyk\|4yyk]], [[4yyn\|4yyn]]</td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4yym FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4yym OCA], [http://pdbe.org/4yym PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4yym RCSB], [http://www.ebi.ac.uk/pdbsum/4yym PDBsum]</span></td></tr>
		+	</table>
		+	== Disease ==
		+	[[http://www.uniprot.org/uniprot/TAF1_HUMAN TAF1_HUMAN]] Defects in TAF1 are the cause of dystonia type 3 (DYT3) [MIM:[http://omim.org/entry/314250 314250]]; also called X-linked dystonia-parkinsonism (XDP). DYT3 is a X-linked dystonia-parkinsonism disorder. Dystonia is defined by the presence of sustained involuntary muscle contractions, often leading to abnormal postures. DYT3 is characterized by severe progressive torsion dystonia followed by parkinsonism. Its prevalence is high in the Philippines. DYT3 has a well-defined pathology of extensive neuronal loss and mosaic gliosis in the striatum (caudate nucleus and putamen) which appears to resemble that in Huntington disease.<ref>PMID:12928496</ref> <ref>PMID:17273961</ref>
		+	== Function ==
		+	[[http://www.uniprot.org/uniprot/TAF1_HUMAN TAF1_HUMAN]] Largest component and core scaffold of the TFIID basal transcription factor complex. Contains novel N- and C-terminal Ser/Thr kinase domains which can autophosphorylate or transphosphorylate other transcription factors. Phosphorylates TP53 on 'Thr-55' which leads to MDM2-mediated degradation of TP53. Phosphorylates GTF2A1 and GTF2F1 on Ser residues. Possesses DNA-binding activity. Essential for progression of the G1 phase of the cell cycle.<ref>PMID:2038334</ref> <ref>PMID:8450888</ref> <ref>PMID:8625415</ref> <ref>PMID:9660973</ref> <ref>PMID:9858607</ref> <ref>PMID:11278496</ref> <ref>PMID:15053879</ref>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Bromodomains are epigenetic readers that are recruited to acetyllysine residues in histone tails. Recent studies have identified non-acetyl acyllysine modifications, raising the possibility that these might be read by bromodomains. Profiling the nearly complete human bromodomain family revealed that while most human bromodomains bind only the shorter acetyl and propionyl marks, the bromodomains of BRD9, CECR2, and the second bromodomain of TAF1 also recognize the longer butyryl mark. In addition, the TAF1 second bromodomain is capable of binding crotonyl marks. None of the human bromodomains tested binds succinyl marks. We characterized structurally and biochemically the binding to different acyl groups, identifying bromodomain residues and structural attributes that contribute to specificity. These studies demonstrate a surprising degree of plasticity in some human bromodomains but no single factor controlling specificity across the family. The identification of candidate butyryl- and crotonyllysine readers supports the idea that these marks could have specific physiological functions.

-	~~The entry 4yym is ON HOLD until Paper Publication~~	+	A Subset of Human Bromodomains Recognizes Butyryllysine and Crotonyllysine Histone Peptide Modifications.,Flynn EM, Huang OW, Poy F, Oppikofer M, Bellon SF, Tang Y, Cochran AG Structure. 2015 Sep 4. pii: S0969-2126(15)00329-9. doi:, 10.1016/j.str.2015.08.004. PMID:26365797<ref>PMID:26365797</ref>

-	~~Authors: Tang~~, Y.~~, Bellon,~~ S.~~, Cochran, A.G., Poy, F~~.	+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
-		+	</div>
-	~~Description~~:	+	<div class="pdbe-citations 4yym" style="background-color:#fffaf0;"></div>
-	[[Category: ~~Unreleased Structures~~]]	+	== References ==
-	[[Category: Cochran, A.G]]	+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Bellon, S]]
		+	[[Category: Cochran, A G]]
	[[Category: Poy, F]]		[[Category: Poy, F]]
-	[[Category: Bellon, S]]
	[[Category: Tang, Y]]		[[Category: Tang, Y]]
		+	[[Category: Bromodomain-butyryllysine complex]]
		+	[[Category: Protein binding]]

OCA at 10:18, 13 May 2015

OCA — Wed, 13 May 2015 10:18:53 GMT

←Older revision		Revision as of 10:18, 13 May 2015
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 4yym is ON HOLD	+	The entry 4yym is ON HOLD until Paper Publication

	Authors: Tang, Y., Bellon, S., Cochran, A.G., Poy, F.		Authors: Tang, Y., Bellon, S., Cochran, A.G., Poy, F.

OCA: Protected "4yym" [edit=sysop:move=sysop]

OCA — Wed, 01 Apr 2015 12:03:35 GMT

Protected "4yym" [edit=sysop:move=sysop]

←Older revision

Revision as of 12:03, 1 April 2015

OCA: New page: '''Unreleased structure''' The entry 4yym is ON HOLD Authors: Tang, Y., Bellon, S., Cochran, A.G., Poy, F. Description: Category: Unreleased Structures Category: Cochran, A.G ...

OCA — Wed, 01 Apr 2015 12:03:34 GMT

New page: '''Unreleased structure''' The entry 4yym is ON HOLD Authors: Tang, Y., Bellon, S., Cochran, A.G., Poy, F. Description: Category: Unreleased Structures Category: Cochran, A.G ...

New page

'''Unreleased structure'''

The entry 4yym is ON HOLD

Authors: Tang, Y., Bellon, S., Cochran, A.G., Poy, F.

Description:
[[Category: Unreleased Structures]]
[[Category: Cochran, A.G]]
[[Category: Poy, F]]
[[Category: Bellon, S]]
[[Category: Tang, Y]]